Ng K, Mogul DB (2018) Pediatric liver tumors. Clin Liver Dis 22(4):753–772
Hubbard AK, Spector LG, Fortuna G et al (2019) Trends in international incidence of pediatric cancers in children under 5 years of age: 1988–2012. JNCI Cancer Spectr 3(1):pkz007
Article PubMed PubMed Central Google Scholar
Spector LG, Birch J (2012) The epidemiology of hepatoblastoma. Pediatr Blood Cancer 59(5):776–779
Lake CM, Tiao GM, Bondoc AJ (2019) Surgical management of locally-advanced and metastatic hepatoblastoma. Semin Pediatr Surg 28(6):150856
Venkatramani R, Stein JE, Sapra A et al (2015) Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg 102(1):108–113
Article CAS PubMed Google Scholar
Aronson DC, Czauderna P, Maibach R et al (2014) The treatment of hepatoblastoma: its evolution and the current status as per the SIOPEL trials. J Indian Assoc Pediatr Surg 19(4):201–207
Article PubMed PubMed Central Google Scholar
Meyers R, Hiyama E, Czauderna P et al (2021) Liver tumors in pediatric patients. Surg Oncol Clin N Am 30(2):253–274
Meyers RL, Maibach R, Hiyama E et al (2017) Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children’s Hepatic tumors International Collaboration. Lancet Oncol 18(1):122–131
Haeberle B, Rangaswami A, Krailo M et al (2020) The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: analysis from the Children’s Hepatic tumors International Collaboration (CHIC) database. Pediatr Blood Cancer 67(8):e28350
Cho SJ, Ranganathan S, Alaggio R et al (2023) Consensus classification of pediatric hepatocellular tumors: a report from the Children’s Hepatic tumors International Collaboration (CHIC). Pediatr Blood Cancer. https://doi.org/10.1002/pbc.30505
Article PubMed PubMed Central Google Scholar
Jiang Y, Luo J, Huang D et al (2022) Machine learning advances in microbiology: a review of methods and applications. Front Microbiol 13:925454
Article PubMed PubMed Central Google Scholar
Tsai SF, Yang CT, Liu WJ et al (2023) Development and validation of an insulin resistance model for a population without diabetes mellitus and its clinical implication: a prospective cohort study. EClinicalMedicine 58:101934
Article PubMed PubMed Central Google Scholar
Feng X, Hong T, Liu W et al (2022) Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma. Front Endocrinol (Lausanne) 13:1054358
Quan B, Li M, Lu S et al (2022) Predicting disease-specific survival for patients with primary cholangiocarcinoma undergoing curative resection by using a decision tree model. Front Oncol 12:824541
Article PubMed PubMed Central Google Scholar
Wang H, Zhou L (2017) Random survival forest with space extensions for censored data. Artif Intell Med 79:52–61
Li K, Yao S, Zhang Z et al (2022) Efficient gradient boosting for prognostic biomarker discovery. Bioinformatics 38(6):1631–1638
Article CAS PubMed PubMed Central Google Scholar
Wang H, Shao Y, Zhou S et al (2022) Support vector machine classifier via L(0/1) soft-margin loss. IEEE Trans Pattern Anal Mach Intell 44(10):7253–7265
Peng ZH, Tian JH, Chen BH et al (2023) Development of machine learning prognostic models for overall survival of prostate cancer patients with lymph node-positive. Sci Rep 13(1):18424
Article CAS PubMed PubMed Central Google Scholar
Kahla JA, Siegel DA, Dai S et al (2022) Incidence and 5-year survival of children and adolescents with hepatoblastoma in the United States. Pediatr Blood Cancer 69(10):e29763
Article CAS PubMed PubMed Central Google Scholar
Allan BJ, Parikh PP, Diaz S et al (2013) Predictors of survival and incidence of hepatoblastoma in the paediatric population. HPB (Oxford) 15(10):741–746
Hung GY, Lin LY, Yu TY et al (2018) Hepatoblastoma incidence in Taiwan: a population-based study. J Chin Med Assoc 81(6):541–547
EL Asmar A, EL Rassi Z (2016) Hepatoblastoma in childhood, long term survival achieved: 2 case reports and literature review. Int J Surg Case Rep 21:55–58
Article PubMed PubMed Central Google Scholar
Towbin AJ, Meyers RL, Woodley H et al (2018) 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT). Pediatr Radiol 48(4):536–554
Katzenstein HM, Langham MR, Malogolowkin MH et al (2019) Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children’s Oncology Group, multicentre, phase 3 trial. Lancet Oncol 20(5):719–727
Article PubMed PubMed Central Google Scholar
Brown J, Perilongo G, Shafford E et al (2000) Pretreatment prognostic factors for children with hepatoblastoma– results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36(11):1418–1425
Article CAS PubMed Google Scholar
VON Schweinitz D (2012) Hepatoblastoma: recent developments in research and treatment. Semin Pediatr Surg 21(1):21–30
Huang J, Hu Y, Jiang H et al (2020) CHIC risk stratification system for predicting the survival of children with hepatoblastoma: data from children with hepatoblastoma in China. Front Oncol 10:552079
Article PubMed PubMed Central Google Scholar
Kim PH, Shin HJ, Yoon HM et al (2022) Children’s hepatic tumors international collaboration-Hepatoblastoma stratification (CHIC-HS) system for pediatric patients with hepatoblastoma: a retrospective, hospital-based cohort study in South Korea. Cancer Res Treat 54(1):253–258
Ke M, Zhou Y, Chang-Zhen Y et al (2022) A nomogram model to predict prognosis of patients with hepatoblastoma. Pediatr Blood Cancer 69(12):e29932
Wang S, Fu S, Li R et al (2024) Construction and validation of nomogram prognostic model for predicting survival in hepatoblastoma patients: a population-based study. Update Surg 76(4):1223–1234
Comments (0)